Characteristics | Discovery cohort | External validation cohort |
---|---|---|
(n = 104) | (n = 84) | |
Median age at diagnosis in years (range) | 50 (24 – 79) | 54.5 (35 – 90) |
Median follow up time from diagnosis in days (range) | 2927.5 (170 – 6125) | 1881.5 (174 – 3807) |
Molecular subtypes | ||
   Luminal A | 62 | 51 |
   Luminal B | 2 | 0 |
   Luminal B HER2 | 10 | 18 |
   Triple Negative | 30 | 15 |
Menopausal status | ||
   Pre | 37 | 24 |
   Post | 75 | 46 |
   Peri | 11 | 3 |
   Unknown | 1 | 11 |
Family history of Breast Cancer | ||
   Yes | 40 | N/A |
   No | 58 | N/A |
   Unknown | 6 | N/A |
Stage | Â | Â |
   I | 8 | 25 |
   II | 79 | 47 |
   III | 16 | 12 |
   IV | 1 | 0 |
Overall Grade | ||
   Low | 36 | N/A |
   High | 67 | N/A |
   Unknown | 1 | N/A |
Vital Status | Â | Â |
   Alive | 58 | 57 |
   Dead | 46 | 27 |
Relapse Status | ||
Relapse | 61 | N/A |
No relapse | 43 | N/A |
Treatment type | ||
   Adjuvant | 79 | 84 |
   Neoadjuvant | 25 | 0 |